Pharmaceutical News

RSS

New app created to help people reduce exposure to anticholinergic medications

A team of researchers from Indiana University School of Medicine, Regenstrief Institute and Purdue University, led by Richard Holden, PhD, is testing a new app, called Brain Safe, designed to help people reduce their exposure to a common class of drugs linked to Alzheimer's disease.

15 Jul 2019

Patients treated with NSAIDs use less opioids

Patients receiving a post-surgery prescription of ibuprofen with a rescue prescription of Percocet used less opioids than a group of similar patients who were prescribed just Percocet.

12 Jul 2019

Nanotechnology-based compound used to deliver hepatitis B vaccine

Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.

11 Jul 2019

New tool promotes greater sharing of clinical trial data by pharmaceutical companies

A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies.

10 Jul 2019

Researchers report how a popular antidepressant drug could rewire the brain

Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988.

10 Jul 2019

Engineered stem cells offer new treatment for metastatic bone cancer

Engineered stem cells could help treat metastatic cancers in bone without killing normal surrounding bone.

9 Jul 2019

Herbal supplement used to treat addiction and pain is not safe, research says

The herb kratom is increasingly being used to manage pain and treat opioid addiction, but it's not safe to use as an herbal supplement, according to new research led by faculty at Binghamton University, State University of New York.

9 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Blood pressure medication associated with increased risk of diverticulosis

A type of blood pressure lowering medication, called a calcium-channel blocker, may be linked with an increased risk of a type of bowel condition called diverticulosis.

3 Jul 2019

Dundee and Bukwang Pharm announce partnership to develop new drug for Parkinson's

The University of Dundee's Drug Discovery Unit has announced a multi-million-pound partnership with Korea-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson's disease.

3 Jul 2019

Study: Antidepressants reduce mortality by 35% in patients with diabetes

Antidepressants reduce deaths by more than a third in patients with diabetes and depression, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

2 Jul 2019

Medicare recipients may pay more for generics than their brand-name counterparts, study finds

Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill.

2 Jul 2019

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

More than 60 years ago, British physician Denis Parsons Burkitt and his associates achieved one of the signal successes in cancer medicine when they cured children in sub-Saharan Africa with a form of lymphoma by treating them with high doses of the chemotherapy drug cyclophosphamide.

2 Jul 2019

Study shows how cannabis could be effective for both pain relief and insomnia

A new study has shown how cannabis could be an effective treatment option for both pain relief and insomnia, for those looking to avoid prescription and over the counter pain and sleep medications -including opioids.

2 Jul 2019

PBS restrictions on anti‐epileptic drug prescribing promote unsafe and outdated care

Prescribing restrictions for anti-epileptic drugs expose flaws in the review process of the Pharmaceutical Benefits Scheme, a University of Queensland researcher proposes.

1 Jul 2019

Supplements claiming to boost brain health are 'too good to be true', warn experts

Dietary supplements that claim to improve brain health probably do not work and are a waste of money for healthy individuals.

1 Jul 2019

Use of statins linked to reduction of mortality risk in dementia patients

The use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Academy of Neurology Congress has shown.

1 Jul 2019

Study examines whether legal mandates for naloxone coprescription increased naloxone dispensing

In a new study published in JAMA Network Open, University of Kentucky researchers, in collaboration with researchers from Ferris State University, examined whether legal mandates on naloxone coprescription in certain states increased naloxone dispensing.

29 Jun 2019

Study reveals lack of evidence for pediatric drugs prescribed to treat chronic pain

Decisions to prescribe children drugs to treat chronic pain are not guided by sufficient, high quality evidence, according to an important new study published today (Wednesday 26 June 2019).

28 Jun 2019

Pharmaceutical products made of solid gold

Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.

28 Jun 2019

Pharmaceutical News

New app created to help people reduce exposure to anticholinergic medications

Patients treated with NSAIDs use less opioids

Nanotechnology-based compound used to deliver hepatitis B vaccine

New tool promotes greater sharing of clinical trial data by pharmaceutical companies

Researchers report how a popular antidepressant drug could rewire the brain

Engineered stem cells offer new treatment for metastatic bone cancer

Herbal supplement used to treat addiction and pain is not safe, research says

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Blood pressure medication associated with increased risk of diverticulosis

Dundee and Bukwang Pharm announce partnership to develop new drug for Parkinson's

Study: Antidepressants reduce mortality by 35% in patients with diabetes

Medicare recipients may pay more for generics than their brand-name counterparts, study finds

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Study shows how cannabis could be effective for both pain relief and insomnia

PBS restrictions on anti‐epileptic drug prescribing promote unsafe and outdated care

Supplements claiming to boost brain health are 'too good to be true', warn experts

Use of statins linked to reduction of mortality risk in dementia patients

Study examines whether legal mandates for naloxone coprescription increased naloxone dispensing

Study reveals lack of evidence for pediatric drugs prescribed to treat chronic pain

Pharmaceutical products made of solid gold

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News